Contact Info & Biography
Education & Training
Memberships & Awards

Thomas F. Anderson, MD

Associate Professor, Department of Dermatology

Selected Publications

  1. Stern RS, Thibodeau LA, Kleinerman AB, Parrish JA, Fitzpatrick TB, and 22 participating investigators (TF Anderson). Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. New England Journal of Medicine. 1979;300:809-813.
  2. Anderson TF, Waldinger TP, Voorhees JJ. UVB phototherapy: an overview. Archives of Dermatology. 1984;120:1502-1507.
  3. Pentland AP, Anderson TF. Plantar fibromatosis responds to intralesional steroids. Journal of the American Academy of Dermatology. 1985;12:212-214.
  4. Stern RS, Anderson TF, Lowe NJ, Voorhees JJ, Armstrong RB, Bickers DR, Harber L, Parrish JA. Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: a randomized study. Journal of the American Academy of Dermatology. 1986;15:546-552
  5. Gupta AK, Anderson TF. Psoralen photochemotherapy: an overview. CME article. Journal of the American Academy of Dermatology. 1987;17:703-734.
  6. Anderson TF, Petersen C, Hamilton T. Meclofenomate inhibition of UV induced erythema - a randomized, placebo controlled, double blind study. Photodermatology. 1989;6:63-68.
  7. Gupta AK, Ellis CN, Tellner DC, Anderson TF, Voorhees JJ. Double-blind, placebo-controlled study to evaluate the efficacy of fish oil and low dose ultraviolet B in the treatment of psoriasis. British Journal of Dermatology. 1989;120:801-807.
  8. Mostow EN, Neckel SL, Oberhelman L, Anderson TF, Cooper KD. Complete remissions in (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA. Arch Dermatol. 1993;129:747-752.
  9. Fader DJ, Stoler MH, Anderson TF. Isolated extragenital HPV-thirties-group-positive bowenoid papulosis in an AIDS patient. Br J Derm. 1994;131:577-580.
  10. Stern RS, Nichols KT, Vakeva LH and 19 collaborating investigators (TF Anderson). Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. N Engl J Med. 1997;336(15):1041-1045.
  11. LeVee GJ, Oberhelman L, Anderson TF, Koren H, Cooper KD. UVA II exposure of human skin results in decreased immunization capacity, increased induction of tolerance and a unique pattern of epidermal antigen presenting cell alteration. Photochem Photobiol. 1997;54(4):622-629.
  12. Stern RS, Liebman EJ, Vakeva LH and PUVA follow-up investigators, (Anderson TF). Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA follow-up study. Journal of the National Cancer Institute. 1998;90(17):1278-1284.
  13. Stern RS. Bagheri S. Nichols K. PUVA follow-up study, (Anderson TF). The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA). Journal of the American Academy of Dermatology. July 2002;47(1):33-39.
  14. Stern RS. PUVA follow-up study, (Anderson, TF). Inpatient hospital care for psoriasis: a vanishing practice in the United States. Journal of the American Academy of Dermatology. September 2003;49(3):445-450.
  15. Lim JL Stern RS, PUVA Follow Up Study (Anderson, TF). High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A- treated patients. Journal of Investigative Dermatology. 2005;124(3):505-513.
  16. Stern RS. Lymphoma risk in psoriasis: results of the PUVA follow-up study. (Anderson, TF). Archives of Dermatology. September 2006;142(9):1132-1135.


U-M Medical School | U-M Gateway
© Copyright 2014-2017 Regents of the University of Michigan | Disclaimer |
Privacy Statement
Developed and maintained by Michigan Multimedia, Medical School Information Services
Contact Michigan Medicine


Michigan Medicine Home
Health Topics A-Z
For Patients & Families
For Health Providers